Support for the Severnside Alliance for Translational Research (SARTRE) - Cardiff

Lead Research Organisation: Cardiff University

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Technical Summary

Cardiff and Bristol Universities were awarded £1,294K to support underpinning the newly formed strategic alliance, the Severnside Alliance for Translational Research (SARTRE). The alliance represents an innovative approach towards translational research.

Publications

10 25 50
 
Title Touchdown Cardiff 
Description Touchdown produced a series of short videos describing aspects of Cardiff University's activities which are available to view on YouTube. Prof Sundstrom, Director of Severnside Alliance for Translational Research (SARTRE), talks about why SARTRE connects people, how research is moving towards a collaborative era and how Cardiff University is approaching research in a novel way 
Type Of Art Film/Video/Animation 
Year Produced 2011 
Impact Unknown 
URL https://www.youtube.com/watch?v=oVEprGGs3zM
 
Description Development of a University Research Institute for Health
Geographic Reach Local/Municipal/Regional 
Policy Influence Type Participation in advisory committee
 
Description Innova Health Open Innovation White Paper
Geographic Reach Asia 
Policy Influence Type Participation in advisory committee
Impact The iNNOVAHEALTH final report: Building an Open Innovation Ecosystem in Europe for Healthcare (Final_Innovahealth_Report.pdf) is now available. The report was launched in the European Parliament on 29th November 2012 (http://euapm.eu/news/12). The personalised medicine agenda is being carried forward by the Irish Presidency and the European Association of Personalised Medicine who have built on the iNNOVAHEALTH recommendations through working groups and these recommendations were discussed at a conference in Dublin on 21st March 2013.
URL http://www.oipharmapartners.com/news/
 
Description NISCHR AHSC Industry Strategy group
Geographic Reach Local/Municipal/Regional 
Policy Influence Type Membership of a guidance committee
Impact Report on task and finish group - Recommendations for devloping interactions with industry - forms industry policy and strategy for AHSC Wales. Led to the creation of "Health Research Wales" and led to the formation of an industry advisory group.
 
Description Report on Best Practice in Translational Research
Geographic Reach Local/Municipal/Regional 
Policy Influence Type Citation in other policy documents
 
Description Report on Best Practice in Translational Research
Geographic Reach Local/Municipal/Regional 
Policy Influence Type Gave evidence to a government review
URL http://www.senedd.assembly.wales/documents/s24734/HSC4-07-14%20Paper%207%20West%20of%20England%20Aca...
 
Description West of England Academic Health Sciences Network
Geographic Reach Local/Municipal/Regional 
Policy Influence Type Participation in advisory committee
URL http://www.senedd.assembly.wales/documents/s24734/HSC4-07-14%20Paper%207%20West%20of%20England%20Aca...
 
Description DPFS Devolved Portfolio
Amount £2,000,000 (GBP)
Organisation Medical Research Council (MRC) 
Sector Academic/University
Country United Kingdom
Start  
 
Description DPFS Resources- A Core Protein Production Facility
Amount £429,787 (GBP)
Funding ID G0801676 
Organisation Medical Research Council (MRC) 
Sector Academic/University
Country United Kingdom
Start  
 
Description Fast Forward Competition 2013
Amount £65,000 (GBP)
Organisation Intellectual Property Office (IPO) 
Sector Public
Country United Kingdom
Start 04/2013 
End 04/2014
 
Description Fast Forward Competition 2014
Amount £65,000 (GBP)
Organisation Intellectual Property Office (IPO) 
Sector Public
Country United Kingdom
Start 04/2014 
End 12/2015
 
Description Translational Imaging Post - Senior Lectureship
Amount £138,516 (GBP)
Organisation Health and Care Research Wales 
Sector Public
Country United Kingdom
Start 01/2009 
End 12/2011
 
Description WT ISSF Bristol University 2
Amount £1,500,000 (GBP)
Organisation Wellcome Trust 
Department Wellcome Trust Institutional Strategic Support Fund
Sector Charity/Non Profit
Country United Kingdom
Start 01/2015 
End 12/2017
 
Description Wellcome Trust ISSF funding
Amount £750,000 (GBP)
Organisation Wellcome Trust 
Department Wellcome Trust Institutional Strategic Support Fund
Sector Charity/Non Profit
Country United Kingdom
Start 09/2012 
End 12/2014
 
Title Health Technology Scheme Interactive Website 
Description This is a website which allows ideas for healthcare improvements to be suggested discussed and voted on. 
Type Of Material Improvements to research infrastructure 
Year Produced 2013 
Provided To Others? Yes  
Impact It had led to number of interactions across the SEWAHSP community and wider with participants from across Wales and England. Although focussed on regional activity with the linked funding scheme only being available to SEWAHSP members this has generated much wider interest. 187 people have joined the forum as of Nov 2013 (launched in June 2013). Update - the Scheme continued to become Health Technology Challenge Wales in 2014 with over 420 members as of Nov 2014. 
URL https://sartre.ideascale.com/a/panel.do
 
Title www.sartre.ac.uk - Website with Members Section 
Description Our Website allows participants in translational research to register as SARTRE Members. Data collected with the purpose of building a network of researchers across disciplines and therapeutic areas, across universities , health trusts, and industry. Available technologies and potential resources to share are asked for, as well as research interests etc. 
Type Of Material Improvements to research infrastructure 
Year Produced 2010 
Provided To Others? Yes  
Impact The provision of research material at translational network meetings enables the discussion of research themes, introduction of translational partners (e.g. lab scientist seeking clinical research partner). 
 
Description Critical Care Alliance 
Organisation Aneurin Bevan University Health Board
Country United Kingdom 
Sector Public 
PI Contribution The collaboration between physicists, mathemeticians and clinicians strengthens the knowledge pathway to identify use and utility of point of care diagnostics.
Collaborator Contribution The input of research active intensive care clinicians allow guidance for sepsis biomarkers and utilisation of developing technology.The input of research active intensive care clinicians allow guidance for sepsis biomarkers and utilisation of developing technology.The input of research active intensive care clinicians allow guidance for sepsis biomarkers and utilisation of developing technology.The input of research active intensive care clinicians allow guidance for sepsis biomarkers and utilisation of developing technology.
Impact This collaboration has already led to a Wellcome HICF full application for funding and two full applications invited by the TSB for Sepsis I and Sepsis II programmes. The group have also applied for an EU COST action and an FP7 project with different consortia. Both applications to the TSB Sepsis I and II programmes were successful gaining £2.7M in total funding.
Start Year 2011
 
Description Critical Care Alliance 
Organisation Cardiff University
Department Department of Anaesthetics, Intensive Care and Pain Medicine
Country United Kingdom 
Sector Academic/University 
PI Contribution The collaboration between physicists, mathemeticians and clinicians strengthens the knowledge pathway to identify use and utility of point of care diagnostics.
Collaborator Contribution The input of research active intensive care clinicians allow guidance for sepsis biomarkers and utilisation of developing technology.The input of research active intensive care clinicians allow guidance for sepsis biomarkers and utilisation of developing technology.The input of research active intensive care clinicians allow guidance for sepsis biomarkers and utilisation of developing technology.The input of research active intensive care clinicians allow guidance for sepsis biomarkers and utilisation of developing technology.
Impact This collaboration has already led to a Wellcome HICF full application for funding and two full applications invited by the TSB for Sepsis I and Sepsis II programmes. The group have also applied for an EU COST action and an FP7 project with different consortia. Both applications to the TSB Sepsis I and II programmes were successful gaining £2.7M in total funding.
Start Year 2011
 
Description Critical Care Alliance 
Organisation Cwm Taf University Health Board
Country United Kingdom 
Sector Public 
PI Contribution The collaboration between physicists, mathemeticians and clinicians strengthens the knowledge pathway to identify use and utility of point of care diagnostics.
Collaborator Contribution The input of research active intensive care clinicians allow guidance for sepsis biomarkers and utilisation of developing technology.The input of research active intensive care clinicians allow guidance for sepsis biomarkers and utilisation of developing technology.The input of research active intensive care clinicians allow guidance for sepsis biomarkers and utilisation of developing technology.The input of research active intensive care clinicians allow guidance for sepsis biomarkers and utilisation of developing technology.
Impact This collaboration has already led to a Wellcome HICF full application for funding and two full applications invited by the TSB for Sepsis I and Sepsis II programmes. The group have also applied for an EU COST action and an FP7 project with different consortia. Both applications to the TSB Sepsis I and II programmes were successful gaining £2.7M in total funding.
Start Year 2011
 
Description Critical Care Alliance 
Organisation University Hospitals Bristol NHS Foundation Trust
Department Intensive Care Unit
Country United Kingdom 
Sector Hospitals 
PI Contribution The collaboration between physicists, mathemeticians and clinicians strengthens the knowledge pathway to identify use and utility of point of care diagnostics.
Collaborator Contribution The input of research active intensive care clinicians allow guidance for sepsis biomarkers and utilisation of developing technology.The input of research active intensive care clinicians allow guidance for sepsis biomarkers and utilisation of developing technology.The input of research active intensive care clinicians allow guidance for sepsis biomarkers and utilisation of developing technology.The input of research active intensive care clinicians allow guidance for sepsis biomarkers and utilisation of developing technology.
Impact This collaboration has already led to a Wellcome HICF full application for funding and two full applications invited by the TSB for Sepsis I and Sepsis II programmes. The group have also applied for an EU COST action and an FP7 project with different consortia. Both applications to the TSB Sepsis I and II programmes were successful gaining £2.7M in total funding.
Start Year 2011
 
Description Honorary Research Fellow visiting from pharmaceutical industry 
Organisation Johnson & Johnson
Country United States 
Sector Private 
PI Contribution The Visiting Fellow will advise SARTRE and associated academics on potential partnerships and collaborations
Collaborator Contribution Has strengthened the links between academia and industry
Impact Recent collaboration
Start Year 2010
 
Description SEWAHSP HealthTechnology Challenge 
Organisation South East Wales Academic Health Sciences Partnerships
Country United Kingdom 
Sector Academic/University 
PI Contribution We are working with SEWAHSP to support their Industry Strategy and we have partnered to support a new initiative, the Health Technology Challenge Scheme - details under Further Funding. We have also brought SEWAHSP involvement into the Welsh government Twinning Initiative with Medicon Village in Sweden. CS subsequently started a half time post with SEWAHSP to continue to run the Health Technology Challenge Scheme which has now expanded to an All Wales initiative and to work on projects increasing innovation in the NHS.
Collaborator Contribution SEWAHSP are supporting initiatives aimed at introducing Clinical pull and clinical input into translational research.
Impact Health Technology Challenge Industry Strategy Group
Start Year 2012
 
Description Twinning Initiative with Medicon Village 
Organisation Government of Wales
Department Life Sciences Hub
Country United Kingdom 
Sector Public 
PI Contribution Provided information, Attended meetings and teleconferences and government and SEWAHSP delegates on visit to Sweden. Am facilitating links between Swedish companies and groups in Wales.
Collaborator Contribution Medicon Village and the Welsh Government are working together to facilitate initernational links particularly in the SME and academic sector across LIfe sciences.
Impact Participation in several international events
Start Year 2011
 
Description Twinning Initiative with Medicon Village 
Organisation Medicon Village
Country Sweden 
Sector Private 
PI Contribution Provided information, Attended meetings and teleconferences and government and SEWAHSP delegates on visit to Sweden. Am facilitating links between Swedish companies and groups in Wales.
Collaborator Contribution Medicon Village and the Welsh Government are working together to facilitate initernational links particularly in the SME and academic sector across LIfe sciences.
Impact Participation in several international events
Start Year 2011
 
Description BioWales 2010 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Health professionals
Results and Impact Regional forum for biotech in Wales. Presented SARTRE and novel collaboration models with private sector

Follow-up discussions
Year(s) Of Engagement Activity 2010
 
Description One Nucleus 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Health professionals
Results and Impact Presentation in London to promote novel collaborative models between industry, academia and health providers.

Follow-up discussions
Year(s) Of Engagement Activity 2010
 
Description Technologies in Translational Research and Development Event 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach Regional
Primary Audience Public/other audiences
Results and Impact Translational Research and Devlopment Event - One day meeting with a mixed audience including academic, commercial, government, nhs and technology transfer professionals.

Has not yet taken place
Year(s) Of Engagement Activity 2010